E-mailhongquchem@qq.com

  • Home
  • About Us
  • Products
    • Inhibitor
    • Impurities
    • Intermediate
    • Others
  • News
  • Custom Synthesis
  • Contact Us

Home> News

News

  • Ozanimod: a potential drug for multiple sclerosis

    Ozanimod: a potential drug for multiple sclerosis

    2020-04-25

  • [recruitment of lung cancer patients] phase II clinical study on the treatment of high-risk advanced lung cancer with fu

    [recruitment of lung cancer patients] phase II clinical study on the treatment of high-risk advanced lung cancer with furaquinidine

    2020-04-21

  • Enterprise news | Chuangsheng group announced that its claudin18.2 humanized monoclonal antibody new drug tst001 was app

    Enterprise news | Chuangsheng group announced that its claudin18.2 humanized monoclonal antibody new drug tst001 was approved by the US FDA to carry out clinical trials

    2020-04-21

  • The latest global trend of DC vaccine research and development

    The latest global trend of DC vaccine research and development

    2020-04-20

  • Design, synthesis and activity evaluation of α - ketoamide derivatives as broad-spectrum inhibitors for coronaviruses an

    Design, synthesis and activity evaluation of α - ketoamide derivatives as broad-spectrum inhibitors for coronaviruses and enteroviruses

    2020-04-20

  • Guidelines for clinical trials of biological analogues for rituximab injection (Draft for comments)

    Guidelines for clinical trials of biological analogues for rituximab injection (Draft for comments)

    2020-04-18

  • First targeted therapy for cholangiocarcinoma! The oral FGFR inhibitor pemazyre (pemigatinib) of Incyte was approved by

    First targeted therapy for cholangiocarcinoma! The oral FGFR inhibitor pemazyre (pemigatinib) of Incyte was approved by FDA

    2020-04-18

  • Zhong Nanshan: two drugs are effective for new coronavirus!

    Zhong Nanshan: two drugs are effective for new coronavirus!

    2020-04-16

  • 共31条数据
  • 上一页
  • 1
  • 2
  • 3
  • 4
  • 下一页
    • About Us
    • About Us
    • Products
    • Inhibitor
    • Impurities
    • Intermediate
    • Others
    • Contact Us
    • Contact Us

Shanghai Hongqu Biomedical Technolog

Tel:

qq:765099555

Email:hongquchem@qq.com

Add:Room 3122, No. 3108, fengzhe Road, Qingcun Town, Fengxian District, Shanghai

Official WeChat

Links: friendlink friendlink

©2020-2030 all rights reserved
  • E-MAIL

  • QQ

  • TEL